Q3 2014 Holdings
Filed 2014-11-14 | 110 holdings | $873.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $507.1M | 20,481,442 | 58.0% |
| Biomarin Pharmaceuticals(BMRN) | COM | 09061G101 | $171.1M | 2,370,464 | 19.6% |
| Biocryst Pharmaceuticals Inc.(BCRX) | COM | 09058V103 | $104.8M | 10,713,686 | 12.0% |
| Cerus(CERS) | COM | 157085101 | $47.9M | 11,940,178 | 5.5% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | COM | 14888U101 | $22.3M | 6,715,462 | 2.6% |
| Agios Pharmaceuticals(AGIO) | COM | 00847X104 | $10.4M | 169,893 | 1.2% |
| Aurinia Pharmaceuticals, Inc.(AUPH) | COM | 05156V102 | $2.3M | 727,669 | 0.3% |
| Pharmacyclics Inc. | COM | 716933106 | $1.1M | 9,656,599 | 0.1% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | COM | 02043Q107 | $906.0K | 11,600 | 0.1% |
| Seattle Genetics, Inc. | COM | 812578102 | $835.6K | 22,475,729 | 0.1% |
| Salix 2.75% 5/15/15 | CONV BONDS | 795435AC0 | $737.0K | $219,440,000 | 0.1% |
| Synageva Biopharma Corp. | COM | 87159A103 | $733.2K | 10,660,432 | 0.1% |
| Incyte Corp.(INCY) | COM | 45337C102 | $728.2K | 14,845,559 | 0.1% |
| Genomic Health Inc.(GHDX) | COM | 37244C101 | $386.6K | 13,655,618 | 0.0% |
| Incyte Corporation Notes 1.25% 11/15/2020 | CONV BONDS | 45337CAL6 | $334.0K | $274,500,000 | 0.0% |
| Incyte Corporation Notes 0.375% 11/15/2018 | CONV BONDS | 45337CAK8 | $308.1K | $259,000,000 | 0.0% |
| Avanir Pharmaceuticals | COM | 05348P401 | $250.0K | 20,974,677 | 0.0% |
| Incyte Corporation Notes 4.75% 10/1/2015 | CONV BONDS | 45337CAJ1 | $225.3K | $40,446,000 | 0.0% |
| Avanir Pharmaceuticals Inc C @ 1.0 OCT 14Call | COM | 05348P401 | $111.5K | 9,356,200 | 0.0% |
| Anacor Pharmaceuticals | COM | 032420101 | $102.9K | 4,204,702 | 0.0% |
| Gilead 1.625% 5/1/16 | CONV BONDS | 375558AP8 | $100.4K | $21,500,000 | 0.0% |
| Xoma Corp. | COM | 98419J107 | $97.1K | 23,071,472 | 0.0% |
| Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 | CONV BONDS | 09061GAD3 | $81.4K | $22,898,000 | 0.0% |
| Medivation 2.625% 4/1/17 | CONV BONDS | 58501NAA9 | $67.7K | $34,720,000 | 0.0% |
| Dyax Corp. | COM | 26746E103 | $62.3K | 6,157,789 | 0.0% |
| Acorda Therapeutics Notes 1.75% 6/15/2021 | CONV BONDS | 00484MAA4 | $62.1K | $60,000,000 | 0.0% |
| Vanda Pharmaceuticals, Inc.(VNDA) | COM | 921659108 | $45.4K | 4,372,153 | 0.0% |
| Mirati Therapeutics Inc.(MRTXEUR) | COM | 60468T105 | $41.7K | 2,380,074 | 0.0% |
| Xenoport | COM | 98411C100 | $36.7K | 6,815,777 | 0.0% |
| Salix 1.5% 3/15/19 | CONV BONDS | 795435AE6 | $36.2K | $15,000,000 | 0.0% |
| Derma Sciences | COM | 249827502 | $29.5K | 3,537,137 | 0.0% |
| Repros Therapeutics | COM | 76028H209 | $27.5K | 2,778,654 | 0.0% |
| Gilead Sciences Inc.(GILD) | COM | 375558103 | $27.3K | 256,108 | 0.0% |
| Acorda Therapeutics, Inc. | COM | 00484M106 | $25.5K | 753,391 | 0.0% |
| Halozyme Therapeutics Inc.(HALO) | COM | 40637H109 | $25.3K | 2,776,143 | 0.0% |
| Versartis Inc. | COM | 92529L102 | $23.7K | 1,246,089 | 0.0% |
| Progenics Pharmaceuticals, Inc. | COM | 743187106 | $23.1K | 4,449,797 | 0.0% |
| TG Therapeutics(TGTX) | COM | 88322Q108 | $21.9K | 2,050,313 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $21.7K | 2,607,784 | 0.0% |
| Mallinckrodt PUB LTD Co | COM | G5785G107 | $18.2K | 201,856 | 0.0% |
| Arrowhead Research Corp. | COM | 042797209 | $18.2K | 1,230,802 | 0.0% |
| Ambit Biosciences Corp. | COM | 02318X100 | $16.8K | 1,093,332 | 0.0% |
| Insmed Inc.(INSM) | COM | 457669307 | $14.5K | 1,107,850 | 0.0% |
| Biomarin Pharmaceuticals Notes 0.75% 10/15/2018 | CONV BONDS | 09061GAE1 | $13.2K | $12,500,000 | 0.0% |
| Omeros Corp.(OMER) | COM | 682143102 | $10.3K | 808,775 | 0.0% |
| Tekmire Pharmaceuticals Corp. | COM | 87911B209 | $10.2K | 484,156 | 0.0% |
| Kythera Biopharmaceuticals | COM | 501570105 | $10.2K | 311,255 | 0.0% |
| Sangamo Biosceiences, Inc.(SGMO) | COM | 800677106 | $9.3K | 864,856 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $8.7K | 554,590 | 0.0% |
| Ultragenyx Pharmaceuticals(RARE) | COM | 90400D108 | $8.5K | 150,000 | 0.0% |